SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy.

Lamont, RF; Jones, BM; Mandal, D; Hay, PE; Sheehan, M (2003) The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect Dis Obstet Gynecol, 11 (4). 181 - 189. ISSN 1064-7449 https://doi.org/10.1080/10647440300025519
SGUL Authors: Hay, Phillip Edward

[img]
Preview
PDF Published Version
Download (412kB) | Preview

Abstract

To assess the efficacy of 2% clindamycin vaginal cream (CVC) to treat bacterial vaginosis (BV) in pregnancy.

Item Type: Article
Additional Information: PMCID: PMC1852293
Keywords: Administration, Intravaginal, Adolescent, Adult, Chi-Square Distribution, Clindamycin, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Probability, Prospective Studies, Reference Values, Risk Assessment, Treatment Outcome, Vaginal Creams, Foams, and Jellies, Vaginal Smears, Vaginosis, Bacterial
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Infect Dis Obstet Gynecol
ISSN: 1064-7449
Dates:
DateEvent
2003Published
PubMed ID: 15108863
Web of Science ID: 15108863
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
Go to PubMed abstract
URI: http://openaccess.sgul.ac.uk/id/eprint/1924
Publisher's version: https://doi.org/10.1080/10647440300025519

Actions (login required)

Edit Item Edit Item